Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · IEX Real-Time Price · USD
19.94
-0.06 (-0.30%)
Mar 28, 2024, 1:16 PM EDT - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $265.57 million as of March 28, 2024. Its market cap has increased by 49.87% in one year.
Market Cap
265.57M
Enterprise Value
256.43M
1-Year Change
49.87%
Ranking
Category
Stock Price
$19.94
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $265.57M, an increase of 286.64%. That is a compound annual growth rate of 47.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 257.00M | -1.57% |
Mar 26, 2024 | 261.10M | 4.48% |
Mar 25, 2024 | 249.90M | -0.87% |
Mar 22, 2024 | 252.10M | 3.70% |
Mar 21, 2024 | 243.10M | 2.96% |
Mar 20, 2024 | 236.10M | 8.40% |
Mar 19, 2024 | 217.80M | -0.46% |
Mar 18, 2024 | 218.80M | -2.67% |
Mar 15, 2024 | 224.80M | 5.99% |
Mar 14, 2024 | 212.10M | -9.28% |
Mar 13, 2024 | 233.80M | -4.88% |
Mar 12, 2024 | 245.80M | 8.19% |
Mar 11, 2024 | 227.20M | 15.21% |
Mar 8, 2024 | 197.20M | -6.94% |
Mar 7, 2024 | 211.90M | 19.92% |
Mar 6, 2024 | 176.70M | 9.41% |
Mar 5, 2024 | 161.50M | -3.00% |
Mar 4, 2024 | 166.50M | -0.30% |
Mar 1, 2024 | 167.00M | 6.91% |
Feb 29, 2024 | 156.20M | 0.64% |
Feb 28, 2024 | 155.20M | -3.36% |
Feb 27, 2024 | 160.60M | 3.48% |
Feb 26, 2024 | 155.20M | -6.56% |
Feb 23, 2024 | 166.10M | -3.54% |
Feb 22, 2024 | 172.20M | 1.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Puma Biotechnology | 256.94M |
OrganiGram Holdings | 255.95M |
Actinium Pharmaceuticals | 255.43M |
Sight Sciences | 254.70M |
Quantum-Si incorporated | 253.77M |
Foghorn Therapeutics | 252.84M |
uniQure | 252.59M |
Rigel Pharmaceuticals | 249.04M |